ABCA1 and metabolic syndrome: In the ApoE−/− mice treated with an HFD and LPS, RES ameliorated dyslipidemia and atherosclerotic lesions in the aortas and coronary arteries, upregulated the expression of ABCA1 in the aortas, and reduced the levels of costimulatory molecules and inflammatory cytokines in spleens and serum.